Freemont Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-218,600
Closed -$5.14M 102
2023
Q1
$5.14M Hold
218,600
0.72% 51
2022
Q4
$6.11M Hold
218,600
0.96% 39
2022
Q3
$5.12M Buy
218,600
+69,520
+47% +$2.1M 0.93% 40
2022
Q2
$5.03M Sell
149,080
-7,600
-5% -$266K 0.87% 48
2022
Q1
$5.47M Buy
+156,680
New +$5.36M 0.83% 54
2021
Q4
Sell
-11,280
Closed -$370K 103
2021
Q3
$370K Hold
11,280
0.05% 88
2021
Q2
$341K Buy
+11,280
New +$371K 0.05% 77

Other funds holding OGN

Freemont Management's OGN Position: Q2 2023 in Review

Freemont Management sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 218,600 shares — an estimated $5.14M sold.

Freemont Management first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $6.11M in Q4 2022. 727 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Freemont Management reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Freemont Management sold 218,600 Organon & Co shares in Q2 2023, an estimated $5.14M.
  • Freemont Management first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Freemont Management's Organon & Co position peaked at $6.11M in Q4 2022.
  • 727 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Freemont Management's 13F filing for Q2 2023, filed 8 Aug 2023.